ACADIA Pharmaceuticals Inc (ACAD) Stock Price

26.025 ▲ +0.635 (+2.50%)
Open: 25.565 Vol: 3.08K Day's range: 25.565 - 26.045 Jul 28, 15:57 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ACAD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 25.99▲ 25.93▲ 25.85▲ 25.21▲ 25.73▲
MA10 25.96▲ 25.84▲ 25.75▲ 25.37▲ 23.99▲
MA20 25.95▲ 25.73▲ 25.38▲ 25.59▲ 22.82▲
MA50 25.85▲ 25.24▲ 25.23▲ 23.31▲ 23.65▲
MA100 25.77▲ 25.24▲ 25.51▲ 22.58▲ 21.02▲
MA200 25.44▲ 25.54▲ 24.82▲ 23.54▲ 20.95▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ 0.006▲ 0.068▲ -0.154▼ 0.497▲
RSI 64.937▲ 66.144▲ 66.312▲ 63.128▲ 61.062▲
STOCH 64.901     90.286▲ 86.184▲ 40.213     75.860    
WILL %R -34.375     -7.857▲ -5.340▲ -21.730▲ -18.474▲
CCI 177.465▲ 129.477▲ 137.000▲ 76.957     85.727    
Latest Filters Detected On ACAD
MA $ACAD Price Crossed Above MA(13) Set Alert
CDL $ACAD Marubozu Candlestick Pattern Detected Set Alert
ACADIA Pharmaceuticals Inc News
ACADIA (ACAD) Upgraded to Buy After Recent Pullback
Saturday, May 02, 2026 06:51 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) ranks among the most profitable biotech stocks to buy now. On March 25, BofA Securities raised ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Buy from Neutral, ...
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
Wednesday, September 24, 2025 04:00 AM
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...
Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short
Wednesday, September 24, 2025 03:05 AM
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...
ACAD historical stock data
date open high low close volume
28/07/26 25.565 26.075 25.565 26.015 923,491
27/07/26 25.21 25.78 24.99 25.39 1,332,317
24/07/26 25.10 25.10 24.57 24.84 982,562
23/07/26 24.232 25.00 24.232 24.83 1,272,012
22/07/26 25.59 25.62 24.91 24.96 1,136,136
21/07/26 25.20 25.57 25.07 25.43 1,284,489
20/07/26 26.07 26.16 25.03 25.09 1,486,528
17/07/26 25.37 25.835 25.20 25.60 1,139,988
16/07/26 26.00 26.23 25.47 25.63 2,114,874
15/07/26 25.38 26.08 25.1804 25.92 1,273,559
Quote Details
52wk Low:19.69
52wk High:28.35
Vol:3.08K
Avg Vol(3m):30.9M
1Y Chng:+3.52%
1M Chng:+22.34%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.25B